Literature DB >> 17056092

What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.

Nelson G Ordóñez1.   

Abstract

Numerous immunohistochemical markers that can assist in the diagnosis of epithelioid mesotheliomas, some of which have only recently been recognized, are currently available. Because the various types of carcinomas express these markers differently, their selection for inclusion in a diagnostic panel can vary according to the differential diagnosis. This article provides a critical review of all of the information that is presently available on those markers that are believed to have the greatest potential for assisting in distinguishing between epithelioid mesotheliomas and those carcinomas with which they are most likely to be confused. Information is also provided regarding the panels of immunohistochemical markers that are, at present, recommended in these differential diagnoses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056092     DOI: 10.1016/j.humpath.2006.08.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  36 in total

1.  PINCH-2 expression in cancers involving serosal effusions using quantitative PCR.

Authors:  Y Yuan; H P Dong; D A Nymoen; J M Nesland; C Wu; B Davidson
Journal:  Cytopathology       Date:  2011-02       Impact factor: 2.073

2.  Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall.

Authors:  Stephanie Barak; Zengfeng Wang; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

3.  Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.

Authors:  Thaer Khoury; Rameela Chandrasekhar; Gregory Wilding; Dongfeng Tan; Richard T Cheney
Journal:  Int J Exp Pathol       Date:  2010-11-02       Impact factor: 1.925

Review 4.  Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.

Authors:  Sinchita Roy Chowdhuri; Patricia Fetsch; Jennifer Squires; Elise Kohn; Armando C Filie
Journal:  Diagn Cytopathol       Date:  2012-11-16       Impact factor: 1.582

Review 5.  Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series and review of the clinical and immunohistochemical features.

Authors:  Salih Taşkın; Yeliz Gümüş; Saba Kiremitçi; Korhan Kahraman; Ayşe Sertçelik; Fırat Ortaç
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

Review 6.  [Pleural mesothelioma. Cytology and molecular diagnostics].

Authors:  T Vlajnic; S Savic; L Bubendorf
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

7.  A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.

Authors:  Hila Benjamin; Danit Lebanony; Shai Rosenwald; Lahav Cohen; Hadas Gibori; Naama Barabash; Karin Ashkenazi; Eran Goren; Eti Meiri; Sara Morgenstern; Marina Perelman; Iris Barshack; Yaron Goren; Tina Bocker Edmonston; Ayelet Chajut; Ranit Aharonov; Zvi Bentwich; Nitzan Rosenfeld; Dalia Cohen
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

8.  Identification of novel markers for the diagnosis of malignant pleural mesothelioma.

Authors:  Fabien Gueugnon; Sabrina Leclercq; Christophe Blanquart; Christine Sagan; Laurent Cellerin; Martine Padieu; Christian Perigaud; Arnaud Scherpereel; Marc Gregoire
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

9.  Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.

Authors:  S Cedrés; M A Montero; E Zamora; A Martínez; P Martínez; L Fariñas; A Navarro; D Torrejon; A Gabaldon; S Ramon Y Cajal; E Felip
Journal:  Clin Transl Oncol       Date:  2013-12-10       Impact factor: 3.405

10.  Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.

Authors:  Irina Raiko; Ingrid Sander; Daniel G Weber; Monika Raulf-Heimsoth; Adrian Gillissen; Jens Kollmeier; Arnaud Scherpereel; Thomas Brüning; Georg Johnen
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.